Optimizing HIV and HCV Treatment and Prevention Among People Experiencing Homelessness
A Live "Coffee Talk" Webinar Series
Arsalan "RC" Shah, PharmD, MBA; Stacey B. Trooskin, MD, PhD, MPH; Sarah E. Rowan, MD; Juliana Wallace LCSW, CADC III


It is well recognized that HIV, HCV, and opioid use disorder are intertwined epidemics that result in increased morbidity and mortality across affected populations. However, people experiencing homelessness (PEH) are disproportionately impacted by this “syndemic,” and clinicians serving this population are challenged to provide effective treatment and prevention services for often hard-to-reach patient subpopulations.


This webinar series will provide critical updates on specific recommendations for HIV and HCV treatment and prevention in PEH, including those with opioid use disorder. Recognizing that providing care for PEH presents challenging implementaion hurdles, educational programming will also address system-level barriers and present real-world models with proven success.

This activity is jointly provided by Global Education Group and Integritas Communications.


This activity is supported by independent educational grants from AbbVie Inc., Gilead Sciences, Inc., and ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.